

Cover Story
Free
By Matthew Bin Han Ong
Jill Biden stopped by at NCI earlier this week to reaffirm the Bidens' pledge to “fight cancer as we know it”—an early signal that cancer research is near the top of the national agenda at the Biden-Harris White House.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for February 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Trump executive order to “Make America Healthy Again” cites questionable data from Wuhan
White House cites paper in pay-to-play journal claiming that U.S. has highest age-standardized incidence rate of cancer - Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - Former CDER Director Patrizia Cavazzoni named Pfizer chief medical officer, executive vice president
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research
- “The Agency finds you are not fit…”
HHS notifications of firing add insult to injury